1. Home
  2. CATO vs SCYX Comparison

CATO vs SCYX Comparison

Compare CATO & SCYX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cato Corporation (The)

CATO

Cato Corporation (The)

HOLD

Current Price

$3.16

Market Cap

58.0M

ML Signal

HOLD

Logo SCYNEXIS Inc.

SCYX

SCYNEXIS Inc.

HOLD

Current Price

$5.53

Market Cap

60.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CATO
SCYX
Founded
1946
1999
Country
United States
United States
Employees
N/A
N/A
Industry
Clothing/Shoe/Accessory Stores
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
58.0M
60.4M
IPO Year
1994
2014

Fundamental Metrics

Financial Performance
Metric
CATO
SCYX
Price
$3.16
$5.53
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$3.00
AVG Volume (30 Days)
94.1K
412.4K
Earning Date
05-21-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
68.04
61.36
EPS
0.47
N/A
Revenue
$653,812,000.00
$257,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$608.78
P/E Ratio
$6.85
N/A
Revenue Growth
0.62
N/A
52 Week Low
$2.52
$0.57
52 Week High
$4.92
$1.29

Technical Indicators

Market Signals
Indicator
CATO
SCYX
Relative Strength Index (RSI) 57.59 94.75
Support Level $2.84 $0.67
Resistance Level $3.31 N/A
Average True Range (ATR) 0.27 0.09
MACD 0.02 0.29
Stochastic Oscillator 42.78 92.48

Price Performance

Historical Comparison
CATO
SCYX

About CATO Cato Corporation (The)

The Cato Corp seeks to offer quality fashion apparel and accessories at low prices every day, in junior/missy and plus sizes. The Cato concept's stores and e-commerce website feature a broad assortment of apparel and accessories, including dressy, career, and casual sportswear, dresses, coats, shoes, lingerie, costume jewelry, and handbags. Management believes the Company's success is dependent upon its ability to differentiate its stores from department stores, mass merchandise discount stores, and competing specialty stores. The key elements of the Company's business are: Merchandise Assortment, Value Pricing, Strip Shopping Center Location, Customer Service, Credit and Layaway Programs.

About SCYX SCYNEXIS Inc.

SCYNEXIS Inc is a drug development company that focuses on the development and commercialization of novel anti-infectives to address unmet therapeutic needs. It is engaged in developing a product candidate, ibrexafungerp which is a novel oral and intravenous (IV) drug for the treatment of several fungal infections, including serious and life-threatening invasive fungal infections. The ibrexafungerp is a novel and structurally distinct triterpenoid glucan synthase inhibitor that is effective in vitro and in vivo against broad range of Candida and Aspergillus species, including drug-resistant strains as well as Pneumocystis, Coccidioides, Histoplasma and Blastomyces genera and some common mucorales species.

Share on Social Networks: